KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Edwards Lifesciences (EW) Net Income towards Common Stockholders (2016 - 2025)

Edwards Lifesciences has reported Net Income towards Common Stockholders over the past 17 years, most recently at $27.0 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 31.3% year-over-year to $27.0 million; the TTM value through Dec 2025 reached $13.4 million, down 99.52%, while the annual FY2025 figure was $13.4 million, 99.52% down from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $27.0 million at Edwards Lifesciences, up from -$2.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $2.7 billion in Q3 2024 and troughed at -$7.2 million in Q1 2025.
  • A 5-year average of $314.6 million and a median of $194.7 million in 2021 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: skyrocketed 5447.75% in 2024 and later crashed 540.0% in 2025.
  • Year by year, Net Income towards Common Stockholders stood at $335.3 million in 2021, then grew by 18.82% to $398.4 million in 2022, then plummeted by 90.81% to $36.6 million in 2023, then increased by 7.38% to $39.3 million in 2024, then tumbled by 31.3% to $27.0 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for EW at $27.0 million in Q4 2025, -$2.0 million in Q3 2025, and -$4.4 million in Q2 2025.